IMARC Group, a leading market research company, has recently releases report titled “Platelet Aggregation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global platelet aggregation devices market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How big is the platelet aggregation devices market?
The global platelet aggregation devices market size reached US$ 525.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 744.7 Million by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028.
Request for PDF Sample of this Report: https://www.imarcgroup.com/platelet-aggregation-devices-market/requestsample
What is platelet aggregation devices?
Platelet aggregation devices are a range of tools that are designed to diagnose the degree of clotting in patient blood. It includes various optical and electrical devices, such as adenosine-diphosphate (ADP), aggrometers, ristocetin-induced platelet aggregation (RIPA), and platelet function analyzer (PFA) as standard devices. These solutions measure the impedance or resistance to blood flow, examine the risk of developing deep vein thrombosis (DVS) and diagnose inherited and acquired platelet function disorders. Apart from this, they perform perioperative bleeding risk assessment and antiplatelet therapy response monitoring in pre-surgery tests, medication transfusions, and clinical settings. As a result, platelet aggregation is utilized by diagnostic laboratories, research institutes, and hospitals for diverse clinical and research applications.
What are the growth prospects and trends in the platelet aggregation devices industry?
The rising prevalence of various chronic, target and cardiovascular disorders (CVDs), especially amongst the geriatric population, and the growing acceptance of platelet-related treatments for various ailments are primarily driving the market growth. In line with this, the increasing demand for platelet screening programs for the identification of dengue and human immunodeficiency (HIV) and ongoing industry-academia collaborations and clinical studies are favoring the market growth. Additionally, significant technological advancements, including the introduction of traditional light transmission aggregometry (LTA) technique, point-of-care testing analyzers, and miniaturized platelet aggregometers are propelling the market growth. Besides this, the rising frequency of platelet aggregation amongst patients diagnosed with coronavirus disease (COVID-19) and the growing consumer awareness regarding the availability of diverse platelet monitoring tools in the healthcare sector are supporting the market growth.
What is included in market segmentation?
The report has segmented the market into the following categories:
Based On Product:
- Systems
- Reagents
- Consumables and Accessories
Based On Type:
- Four Channel
- Dual Channel
- Eight Channel
Based On Application:
- Clinical Applications
- Research Applications
- Cardiovascular Applications
- Orthopedic Applications
- Others
Based On End User:
- Hospitals
- Diagnostic Laboratories
- Research and Academic Institutes
- Others
Based On Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- Aggredyne Inc
- Chrono-Log Corporation
- Hoffmann-La Roche AG
- Grifols S.A
- Hart Biologicals Ltd
- Helena Laboratories Corporation
- LAbor BioMedical Technologies GmbH
- Matis Medical Inc
- Sentinel Ch. S.P.A
- Siemens AG, Sienco Inc
- Sysmex Corporation
- WerfenLife SA.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
